536 Results

Biosimilar adalimumab pitched against Humira in US

 Added 6 days ago

Biosimilar adalimumab is filed at FDA to treat inflammatory diseases.

CLARITY study shows superiority of Cosentyx over Stelara in patients with plaque psoriasis

 Added 6 days ago

CLARITY study shows superiority of Cosentyx over Stelara in patients with plaque psoriasis

Novartis announced results from the head-to-head CLARITY study demonstrating the superiority of Cosentyx (secukinumab) compared to Stelara (ustekinumab) in delivering...

Novartis initiates head to head trials of Cosentyx with biosimilar adalimumab in ankylosing spondylitis (SURPASS) and with Humira in psoriatic arthritis (EXCEED).

 Added 13 days ago

Novartis announces key biosimilar trials in ankylosing spondylitis and psoriatic arthritis.

Once daily acne treatment approved by FDA

 Added 1 month ago

FDA accepts filing of Seysara for acne

NICE rejects Scenesse as not cost effective

 Added 1 month ago

A proposed treatment for erythropoietic protoporphyria has been rejected by the UK body NICE.

New: Symposium videos & presentations for immunologists, dermatologists and allergists

 Added 1 month ago

EADV 2017 highlights published to the CSU Knowledge Centre

Next-generation neuromodulator announced amid successful trials

 Added 1 month ago

Daxibotulinumtoxin A in two trials positive for alleviating glabellar lines

Plaque Psoriasis trial results announced

 Added 1 month ago

Phase III trial of ABBV 066 meets primary endpoints in plaque psoriasis

FDA approves Taltz to treat psoriatic arthritis

 Added 1 month ago

Eli Lilly and Company announced that the FDA has approved Taltz (ixekizumab) injection 80 mg/mL for the treatment of adults with active psoriatic arthritis (PsA).

Adoptive T cell therapy, advanced melanoma and survival

 Added 1 month ago

Adoptive T cell therapy, advanced melanoma and survival

Immunotherapy is a quickly evolving field, offering cures for diseases that were previously terminal. A newly emerging immunotherapy for advanced metastatic melanoma could prove to be a revolutionary treatment.

Load more